single page -

Data Table

Quarterly Table

Date Begin	Date End	Net Sales	Net Profit	Total Income	Diluted EPS for continuing operation	Other Expenses	Other Income	Depreciation and amortisation expense	Profit (+)/ Loss (-) from Ordinary Activities before Tax
2024-01-01	2024-03-31	711.73	147.89	716.33	3.75	-	4.60	-111.82	241.00
2023-10-01	2023-12-31	593.35	157.24	618.69	4.21	-46.55	25.34	-110.58	211.59
2023-10-01	2023-12-31	577.10	205.48	602.53	5.44	-45.51	25.43	-49.00	259.83
2023-07-01	2023-09-30	328.51	24.79	339.59	0.37	-45.34	11.07	-48.39	30.68
2023-07-01	2023-09-30	331.88	-34.37	342.95	-0.49	-45.86	11.07	-109.40	-28.48
2023-04-01	2023-06-30	341.73	6.27	353.84	0.17	-	12.11	-52.87	8.55
2023-04-01	2023-06-30	345.48	-54.64	354.73	-1.40	-44.98	9.25	-113.00	-52.36
2023-01-01	2023-03-31	460.85	80.40	473.94	2.24	-17.90	13.09	-49.03	116.79
2023-01-01	2023-03-31	466.23	20.08	480.33	0.61	-	14.10	-108.62	56.48
2022-10-01	2022-12-31	544.29	77.27	562.21	2.14	-	17.92	-93.05	114.91
2022-10-01	2022-12-31	540.70	136.17	558.83	3.71	-	18.13	-32.38	173.81
2022-07-01	2022-09-30	373.82	32.30	393.09	1.36	-	19.27	-89.04	34.31
2022-07-01	2022-09-30	371.35	90.52	390.42	2.55	-	19.07	-30.15	92.52
2022-04-01	2022-06-30	426.94	19.68	440.67	1.19	-	13.72	-81.39	44.27
2022-04-01	2022-06-30	426.23	77.51	440.34	2.26	-	14.12	-24.96	102.09
2022-01-01	2022-03-31	354.44	-410.77	371.09	2.05	-	16.65	-49.12	-389.07
2022-01-01	2022-03-31	354.44	-936.81	373.31	-27.69	-	18.87	-27.07	-915.11
2021-10-01	2021-12-31	390.26	64.20	396.07	2.55	-	5.81	-46.39	87.70
2021-10-01	2021-12-31	390.26	90.19	398.75	2.78	-	8.48	-23.85	113.68
2021-07-01	2021-09-30	314.86	64.47	324.35	1.87	-	9.49	-25.47	63.58
2021-07-01	2021-09-30	314.86	37.83	321.53	1.63	-28.71	6.67	-48.01	36.95
2021-04-01	2021-06-30	136.73	-88.11	141.29	-2.73	-	4.56	-47.82	-94.27
2021-04-01	2021-06-30	136.73	-61.64	144.00	-1.91	-	7.27	-25.52	-67.81
2021-01-01	2021-03-31	312.25	-210.41	322.72	-6.54	-	10.47	-27.19	-239.78
2021-01-01	2021-03-31	312.25	-269.84	320.60	-8.39	-35.67	8.36	-49.25	-299.28
2020-10-01	2020-12-31	231.89	41.47	236.30	1.33	-25.01	4.41	-24.43	40.65
2020-10-01	2020-12-31	231.89	14.96	233.62	1.06	-	1.73	-46.99	14.14
2020-07-01	2020-09-30	215.40	27.87	215.31	1.55	-	-0.08	-45.67	27.96
2020-07-01	2020-09-30	215.40	60.36	217.87	1.93	-	2.48	-23.11	60.45
2020-04-01	2020-06-30	36.06	-264.76	45.72	-8.46	-115.65	9.67	-23.44	-261.15
2020-04-01	2020-06-30	36.06	-290.87	43.12	-8.71	-116.08	7.07	-45.75	-287.26
2020-01-01	2020-03-31	191.00	-87.67	212.66	-2.80	-53.53	21.67	-52.87	-86.85
2020-01-01	2020-03-31	191.00	-61.14	215.12	-1.95	-53.02	24.13	-30.53	-60.33
2019-10-01	2019-12-31	280.32	19.52	289.39	0.61	-	9.07	-29.22	6.77
2019-10-01	2019-12-31	280.32	-6.86	286.89	0.34	-	6.57	-51.82	-19.61
2019-07-01	2019-09-30	276.41	6.71	285.18	0.77	-51.13	8.77	-53.12	-1.31
2019-07-01	2019-09-30	276.41	33.44	287.87	1.06	-	11.47	-30.52	25.43
2019-04-01	2019-06-30	370.09	63.51	375.91	2.00	-	5.82	-30.47	68.07
2019-04-01	2019-06-30	370.09	36.95	373.29	1.70	-	3.20	-52.81	41.51
2019-01-01	2019-03-31	404.61	34.71	411.50	1.10	-	6.90	-22.36	48.79
2018-10-01	2018-12-31	305.14	30.15	310.64	0.94	-	5.50	-39.16	34.16
2018-07-01	2018-09-30	255.01	23.57	266.17	-	-	11.16	-19.47	29.37
2018-04-01	2018-06-30	223.18	34.53	238.40	-	-33.88	15.23	-	40.20
2018-01-01	2018-03-31	259.43	17.66	261.32	-	-56.05	1.89	-	40.98
2018-01-01	2018-03-31	310.63	60.64	313.74	-	-56.67	3.10	-12.50	82.54
2017-10-01	2017-12-31	303.33	63.62	316.71	-	-	13.38	-	66.17
2017-10-01	2017-12-31	303.33	85.27	318.02	-	-	14.70	-12.47	100.81
2017-07-01	2017-09-30	293.03	83.13	305.24	-	-	12.21	-20.01	102.27
2017-07-01	2017-09-30	293.03	44.85	303.90	-	-	10.87	-	63.99
2017-04-01	2017-06-30	281.88	81.02	296.58	-	-	14.71	-20.57	101.00

Date Begin	Date End	Net Sales	Net Profit	Total Income	Diluted EPS for continuing operation	Other Expenses	Other Income	Depreciation and amortisation expense	Profit (+)/ Loss (-) from Ordinary Activities before Tax
2024-01-01	2024-03-31	711.73	147.89	716.33	3.75	-	4.60	-111.82	241.00
2023-10-01	2023-12-31	577.10	205.48	602.53	5.44	-45.51	25.43	-49.00	259.83
2023-10-01	2023-12-31	593.35	157.24	618.69	4.21	-46.55	25.34	-110.58	211.59
2023-07-01	2023-09-30	328.51	24.79	339.59	0.37	-45.34	11.07	-48.39	30.68

Compounded Sales Growth
10 Years:	10%
5 Years:	10%
3 Years:	35%
TTM:	8%

Compounded Profit Growth
10 Years:	21%
5 Years:	30%
3 Years:	87%
TTM:	22%

Stock Price CAGR
10 Years:	25%
5 Years:	45%
3 Years:	65%
1 Year:	89%

Compounded Sales Growth
10 Years:	0%
5 Years:	12%
3 Years:	36%
TTM:	9%

Compounded Profit Growth
10 Years:	0%
5 Years:	62%
3 Years:	48%
TTM:	57%

Stock Price CAGR
10 Years:	25%
5 Years:	45%
3 Years:	65%
1 Year:	89%

Latest News

Genesys Recognized with Five Stevie® Awards for Great Customer Service and Innovation
Genesys International Corporation Ltd. today announced that it has been recognized with five Stevie® Awards in the 18th Annual Stevie Awards for Sales & Customer Service. The company earned two Gold Stevie Awards for Customer Service Department of the Year and Customer Service Innovation of the Year, and three Silver Stevie Awards for Contact Center of the Year, Customer Service Professional of the Year, and Innovation in Customer Service Technology.
Genesys and T-Mobile Austria Partner to Enhance Customer Experience and Drive Business Growth
Genesys International Corporation Ltd. announced today that T-Mobile Austria has selected Genesys Cloud CX to power its customer engagement strategy. By deploying Genesys Cloud CX, T-Mobile Austria will streamline its customer interactions across all channels, providing a seamless and personalized experience for its customers.
Genesys Launches Genesys Multicloud CX, Enabling Enterprises to Achieve Customer Engagement Agility
Genesys International Corporation Ltd. today announced the launch of Genesys Multicloud CX, the industry's first true multicloud customer experience platform. Genesys Multicloud CX provides enterprises with the flexibility, agility, and security they need to deliver exceptional customer experiences in today's rapidly changing business environment.
Genesys Positioned as a Leader in 2023 Gartner Magic Quadrant for Contact Center as a Service
Genesys International Corporation Ltd. today announced that it has been positioned as a Leader in the 2023 Gartner Magic Quadrant for Contact Center as a Service (CCaaS). This is the 15th consecutive year that Genesys has been recognized as a Leader in the Gartner Magic Quadrant for CCaaS.
Genesys and Google Cloud Partner to Deliver a Unified Customer Engagement Platform
Genesys International Corporation Ltd. today announced a strategic partnership with Google Cloud to deliver a unified customer engagement platform that will help businesses connect with their customers more effectively and efficiently.
Genesys Announces Key Capabilities to Enhance Digital-First Customer Engagement
New innovations empower businesses to deliver effortless omnichannel experiences, drive personalization, and build deeper customer relationships.
Genesys Positioned as a Leader in the 2023 Gartner Magic Quadrant for Contact Center as a Service
Recognition underscores Genesys' commitment to innovation and customer success in the CCaaS market.
Genesys Cloud CX Receives Frost & Sullivan 2022 Global Company of the Year Award
Award recognizes Genesys' leadership in driving customer experience innovation and empowering businesses to create empathetic customer journeys.
Genesys International Corporation Ltd. Announces Expanded Distribution Agreement with Amgen Inc.
Genesys International Corporation Ltd. (TSX: GSY) ("Genesys" or the "Company"), a global leader in the commercialization of innovative medical technologies, announced today that it has entered into an expanded distribution agreement with Amgen Inc. ("Amgen"), a world leader in biotechnology.
Genesys International Corporation Ltd. Appoints New Independent Director
Genesys International Corporation Ltd. (TSX: GSY) ("Genesys" or the "Company"), a global leader in the commercialization of innovative medical technologies, today announced the appointment of Ms. Linda G. Adamany as an independent director to the Company's Board of Directors, effective February 21, 2023.
Genesys International Corporation Ltd. Reports Record Fourth Quarter and Fiscal 2022 Financial Results
Genesys International Corporation Ltd. (TSX: GSY) ("Genesys" or the "Company"), a global leader in the commercialization of innovative medical technologies, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2022.

Genesys International Corporation Ltd.

Short Description

Long Description

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

Quarterly Table

Latest News